Is PTCT stock a Buy, Sell, or Hold?

Based on our analysis, PTCT is currently a HOLD with low confidence. 📊 HOLD: PTCT shows mixed signals. Fine to hold existing positions. Not urgent to buy or sell.

What is the fair value of PTCT stock?

Our analysis estimates the fair value range for PTCT to be between $65.05 and $71.20. The current price is $63.46.

What is the analyst price target for PTCT?

The average Wall Street analyst price target for PTCT is $101.79. This implies a potential upside of 60.4% from current levels.

PTC Therapeutics (PTCT) Stock: Buy, Sell, or Hold?

PTCT - PTC Therapeutics, Inc.

PHARMACEUTICAL PREPARATIONS

$63.46

-0.67 (-1.04%) ▼

5d: +1.26%

30d: -11.6%

90d: -25.73%

HOLD

LOW Confidence

Protect Your PTCT Gains

Analysis Updated: Oct 2, 2026 12:00 AM ET

Earnings: Nov 03, 2026 29d

Smart Money Accumulation

Options open interest is building while the stock consolidates - a pattern consistent with institutional accumulation. View Scanner →

Signal fired Sep 30, 2026 at $64.78 · last confirmed Sep 30, 2026

Strength: 7.6/10

Get Alerted When PTCT Hits Your Target Price

Join 10,000+ traders who never miss a move

You're in! Check your email to confirm and set your target price.

100% Free No spam, ever Unsubscribe anytime

Interactive Price Chart (1 Month)

Loading historical data...

💡

Bottom Line:
📊 HOLD: PTCT shows mixed signals. Fine to hold existing positions. Not urgent to buy or sell.

See Forward Earnings Fair Value & Price Prediction →

Long-Term Wealth Forecast (2031)

Based on Analyst Consensus Growth & Historical Valuation

Adjust Growth Assumption: 25.0%

0% (Stagnation) 50% (Hyper Growth)

EST. PRICE IN 2031

$130.31

Based on 14.5% avg growth

INTRINSIC VALUE TODAY

$80.91

21.6% Margin of Safety

How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 25.0x Exit PE.

View Full DCF Model

In-depth Analysis How we analyze

Valuation Analysis: PTCT is currently trading at $63.46, which is considered slightly low relative to its 30-day fair value range of $65.05 to $71.20. From a valuation perspective, the stock is trading at a discount (Forward PE: 23.7) compared to its historical average (27.0). Remarkably, the market is currently pricing in an annual earnings decline of 4.2% over the next few years. This aligns with recent fundamental challenges.

Technical Outlook: Technically, PTCT is in a downtrend. Immediate support is located at $61.23, while resistance sits at $66.58.

Market Sentiment: PTCT scores 62/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. Wall Street analysts see significant upside, with an average price target of $101.79 (+60.4%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.

Quick Decision Summary

Current Position SLIGHTLY LOW

Historical Trading Range $65.05 - $71.20

Company Quality Score 54/100 (HOLD)

Volume Confirmation HIGH

Confidence Score 90.5%

Protect Your Profits

Holding PTCT? Use our AI-powered strategies to protect your downside while keeping your long-term position.

View Profit Protection Plan

All Signals

BULLISH: Price oversold vs 30-day range
BULLISH: Strong technical setup (62/100)
BULLISH: High volume confirmation
BULLISH: Trading 60.4% below Wall St target ($101.79)
CAUTION: Bottoming setup, but lagging the sector by 25% over 20 days — wait for relative strength

Trading Range Analysis

30-Day Trading Range $65.05 - $71.20

Current vs Trading Range SLIGHTLY LOW

Support & Resistance Levels

Support Level $61.23

Resistance Level $66.58

Current Trend Downtrend

Technical data as of Oct 2, 2026

Fundamental Context

Forward P/E (Next Year Est.) 23.71

Wall Street Target $101.79 (+60.4%)

Revenue Growth (YoY) 101.5%

Profit Margin -3.8%

Valuation Discount vs History -4.2% cheaper

PE vs Historical 23.7 vs 27.0 CHEAP

Market-Implied Price Targets If current PE multiple persists

Implied Growth (YoY): -4.2% (market-implied from PE analysis)

1-Year Target $60.79 (-4%)

2-Year Target $58.24 (-8%)

3-Year Target $55.80 (-12%)

3-Yr Target (if PE normalizes) (PE: 24→27) $63.54 (+0%)

3-Year Scenarios Using analyst projected EPS growth

Bull: (PE: 23.7, Growth: 56.5%) $214.18 (+238%)

Base: (SPY PE: 20.4, Growth: 56.5%) $184.29 (+190%)

Bear: (PE: 17.3, Growth: 56.5%) $156.65 (+147%)

💡 Upside Surprise Potential

If earnings stabilize (0% growth), PE could expand from 23.7 to 27.0

Stabilization Target: $72.27 (+13.9%)

PE Expansion Potential: +13.9%

Share & Embed Analysis

Found this analysis useful? Share it with your community or embed the live chart on your blog.

Tweet Reddit

bloggers & journalists: you are free to use our charts with attribution.

Last updated: October 03, 2026 7:02 PM ET
Data refreshes hourly during market hours. Next update: 8:02 PM

🔥 Top Stocks Breaking Out Now

Ticker	Score	Recommendation	Change %

See Full Scanner Results »

Technical Signals Check

Is PTCT showing a specific setup today?

RSI Divergence Check TTM Squeeze Check MACD Crossover Check Gamma Walls Check Unusual Activity Check

Insider Activity (6 Months)

Buys

Sells

Net

INSIDERS SELLING

Recent Transactions

Matthew B Klein SELL 2850 shares 2026-04-21

View Insider Activity Scanner

Unlock Insider Activity

See real-time buying/selling by company executives for PTCT.

Create Free Account

Already have an account? Log In

Top Rated Biotechnology Stocks

Top-rated stocks in Biotechnology by analyst ratings.

Stock	Analyst Consensus	Analyst Target	Tradestie Score
NTLA Intellia Therapeutics Inc	STRONG BUY 29 analysts	$24	54 HOLD
SRPT Sarepta Therapeutics Inc	STRONG BUY 26 analysts	$22	49 HOLD
ARGX argenx NV ADR	STRONG BUY 22 analysts	$1180	52 HOLD
LEGN Legend Biotech Corp	STRONG BUY 22 analysts	$47	46 HOLD
KYMR Kymera Therapeutics Inc	STRONG BUY 20 analysts	$139	55 HOLD

NTLA Intellia Therapeu…

54 HOLD

SRPT Sarepta Therapeut…

49 HOLD

ARGX argenx NV ADR

52 HOLD

LEGN Legend Biotech Co…

46 HOLD

KYMR Kymera Therapeuti…

55 HOLD

Advanced PTCT Option Strategies

Professional options setups generated by AI based on today's PTCT price and gamma walls.

Iron Condor Bull Call Bear Put Collar

More Analysis for PTCT

PTCT Technical Chart PTCT Price Prediction PTCT Earnings Date PTCT Investment Advisor PTCT Fair Price Analyzer PTCT Options Advisor PTCT Options Chain PTCT Options Analysis PTCT Competitors

Compare PTCT with Peers

PTCT vs AGIO
Which one to buy?

PTCT vs RARE
Which one to buy?

PTCT vs PRTA
Which one to buy?

PTCT vs ENTA
Which one to buy?

PTCT vs PBYI
Which one to buy?

NKTX vs PTCT

IRON vs PTCT

AACB vs PTCT

PRTA vs PTCT
Winner: PTCT

IMVT vs PTCT

CRSP vs PTCT

LVTX vs PTCT

PTCT vs UNCY
Winner: PTCT

ERAS vs PTCT

SRRK vs PTCT

Create New Comparison View All Competitors

Tradestie